Cantor Fitzgerald, L. P. »

Vertex Pharmaceuticals Incorporated shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 36k 347.74
2023-06-30 $13M 36k 351.91
2023-03-31 $11M 34k 315.07
2022-12-31 $9.6M 33k 288.78

More positions owned by Cantor Fitzgerald, L. P.

Acelrx Pharmaceuticals Com New (TLPH)
Ramaco Res Com Cl A (METC)
Gcm Grosvenor Com Cl A (GCMG)
Senseonics Hldgs (SENS)
Rumble Com Cl A (RUM)
22nd Centy Group Com New (XXII)
Proshares Tr Ultrapro Qqq (TQQQ)
Xbp Europe Holdings (XBP)
Wework Cl A New (WEWKQ)
Moneyhero Ord Shs (MNY)
Meta Platforms Cl A (META)
Satellogic Class A Ord Shs (SATL)
GSK Sponsored Adr (GSK)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated